Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;39(3):146-157.
doi: 10.1016/j.tins.2016.01.008. Epub 2016 Feb 15.

There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases

Affiliations
Review

There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases

Sebastien Paillusson et al. Trends Neurosci. 2016 Mar.

Abstract

Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis with associated frontotemporal dementia (ALS/FTD) are major neurodegenerative diseases for which there are no cures. All are characterised by damage to several seemingly disparate cellular processes. The broad nature of this damage makes understanding pathogenic mechanisms and devising new treatments difficult. Can the different damaged functions be linked together in a common disease pathway and which damaged function should be targeted for therapy? Many functions damaged in neurodegenerative diseases are regulated by communications that mitochondria make with a specialised region of the endoplasmic reticulum (ER; mitochondria-associated ER membranes or 'MAM'). Moreover, several recent studies have shown that disturbances to ER-mitochondria contacts occur in neurodegenerative diseases. Here, we review these findings.

Keywords: Alzheimer's disease; Parkinson's disease; amyotrophic lateral sclerosis/fronto-temporal dementia; endoplasmic reticulum; mitochondria; mitochondria associated ER membranes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electron Microscope Images of Endoplasmic Reticulum (ER)-–Mitochondria Contacts in NSC34 Motor Neuron Cells. A control cell is shown (CTRL) (A) along with a cell transfected with the tethering proteins vesicle-associated membrane protein-associated protein B (VAPB) and protein tyrosine phosphatase interacting protein 51 (PTPIP51) (B) . Some selected ER–mitochondria associations are highlighted in red. Transfection of VAPB and PTPIP51 dramatically increases ER–mitochondria associations. (C) A high-magnification image of a mitochondrion with associated ER in a VAPB/PTPIP51 co-transfected cell; putative tethering structures are discernible connecting the two organelles (arrowheads). Scale bars = 500 nm (A,B) and 100 nm (C).
Figure 2
Figure 2
Proposed Endoplasmic Reticulum (ER)–Mitochondria Tethering Protein Complexes. (A) Inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) and voltage-dependent anion channel (VDAC) interact via GRP75. (B) ER-located mitofusin 2 interacts with mitochondrial mitofusin1/2 (Mfn1, Mfn2). (C) Vesicle-associated membrane protein-associated protein B (VAPB) binds to protein tyrosine phosphatase interacting protein 51 (PTPIP51). (D) (Bap31) binds to Fission 1 homologue (Fis1).
Figure 3
Figure 3
Tar DNA-Binding Protein 43 (TDP-43) Loosens Endoplasmic Reticulum (ER)–Mitochondria Associations in Amyotrophic Lateral Sclerosis with Associated Frontotemporal Dementia (ALS/FTD). (A) Normal situation. (B) Disease situation. TDP-43 induces activation glycogen synthase kinase 3β (GSK-3β), which then disrupts binding of vesicle-associated membrane protein-associated protein B (VAPB) to protein tyrosine phosphatase interacting protein 51 (PTPIP51) to reduce ER–mitochondria associations and Ca2+ exchange between the two organelles.
Figure 4
Figure 4
Disruption to Endoplasmic Reticulum (ER)–Mitochondria Associations Provides a Mechanism by which many of the Disparate Pathological Features of Neurodegenerative Diseases Might Arise.

References

    1. Ling S.C. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416–438. - PMC - PubMed
    1. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science. 2006;314:777–781. - PubMed
    1. Hardy J. A hundred years of Alzheimer's disease research. Neuron. 2006;52:3–13. - PubMed
    1. Cookson M.R., Bandmann O. Parkinson's disease: insights from pathways. Hum. Mol. Genet. 2010;19:R21–R27. - PMC - PubMed
    1. Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2011;8:108–117. - PubMed

Publication types

MeSH terms